On March 25, 2024, Novo Nordisk A/S reported a share repurchase program initiated on February 6, 2024, aiming to buy back shares worth up to DKK 20 billion over 12 months. As of March 22, 2024, they have repurchased 1,429,500 B shares totaling approximately DKK 1.23 billion at an average price of DKK 861.63.